he potential of circHIPK3 as a biomarker in chronic myeloid leukemia: Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by leukocytosis and left shift. The primary molecular alteration is the… … #oncology https://t.co/3DypQkJLfS
19,237 followers
12,115 followers
RT @FrontOncology: New research: The potential of circHIPK3 as a biomarker in chronic myeloid leukemia: Chronic myeloid leukemia (CML) is a…
6,541 followers
New research: The potential of circHIPK3 as a biomarker in chronic myeloid leukemia: Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by leukocytosis and left shift. The primary molecular alteration is the… https://t.co/PRZCJUT